Xenon-133 gas

Approved Use:
  • Evaluation of pulmonary function
  • Imaging of the lungs
  • Assessment of cerebral blood flow
Dose:
  • Pulmonary function/imaging: 2 - 30 mCi inhalation
  • Cerebral blood flow: 10 - 30 mCi inhalation
Manufacturer: Lantheus  
Package Insert
How Supplied:
  • 10 mCi vial - 1 vial per tube
  • 10 mCi vial - 5 vials per tube
  • 20 mCi vial - 1 vial per tube
  • 20 mCi vial - 5 vials per tube
Volume: 3 mL/vial
Calibration: Wednesday @ 12:00 ET
Expiration: 10 days after calibration 
Availability:
  • First available to ship Wednesday for early AM delivery on Thursday
  • Arrives 6 days pre-cal
  • See activity chart below
​NDC #: 
11994-127-11 
11994-127-15 
11994-128-21
11994-128-25
​
Letter from Manufacturer March 2016 (Calidose™ Dispenser)
Letter from Manufacturer September 2014 (change in packaging)
Instructions for Lead Shipping Tube
Calidose™ Dispenser System
Manufacturer: Curium
Package Insert
How Supplied: 
  • 10 mCi vial - 1 vial per tube
  • 10 mCi vial - 3 vials per tube
  • 10 mCi vial - 5 vials per tube
  • 20 mCi vial - 1 vial per tube
  • 20 mCi vial - 3 vials per tube
  • 20 mCi vial - 5 vials per tube
Volume: 2 mL/vial
Calibration: Wednesday @ 12:00 CT
Expiration: 14 days after calibration
Availability: 
  • First available to ship Wednesday for early AM delivery on Thursday  
  • Arrives 6 days pre-cal.​
  • See activity chart below
NDC #: 
69945-097-11
69945-097-13
​69945-097-15
69945-098-21
69945-098-23
69945-098-25

Activity Chart (from Curium website)
Xenotron™ I Gas Dispenser Instructions
Xenotron™ I Gas Dispenser Image
Xenon-133 Activity Chart:
Lantheus @ 12:00 ET
Curium @ 12:00 CT
Calibration Day
Day
10 mCi
20 mCi
-7
Wednesday
25.22
50.44
-6
Thursday
22.09
44.18
-5
Friday
19.36
38.72
-4
Saturday
16.97
33.94
-3
Sunday
14.87
29.74
-2
Monday
13.03
26.06
-1
Tuesday
11.41
22.82
Calibration Day @ 12:00
Wednesday
10.00
20.00
+1
Thursday
8.76
17.52
+2
Friday
7.68
15.36
+3
Saturday
6.73
13.46
+4
Sunday
5.89
11.78
+5
Monday
5.16
10.32
+6
Tuesday
4.53
9.06
+7
Wednesday
3.97
7.94
Clinical Guidelines: